Member of the Association of American Physicians
Douglas B. Cines mainly focuses on Immunology, Antibody, Molecular biology, Platelet and Platelet factor 4. The concepts of his Antibody study are interwoven with issues in Immunological infertility, Immune system and Antigen. His work carried out in the field of Molecular biology brings together such families of science as Endothelial stem cell, Biochemistry, High-molecular-weight kininogen, Monoclonal antibody and Polyclonal antibodies.
His Platelet study is concerned with the larger field of Internal medicine. His research integrates issues of Platelet activation, Vascular disease and Heparin-induced thrombocytopenia in his study of Platelet factor 4. In his study, which falls under the umbrella issue of Heparin, Thrombosis is strongly linked to Anticoagulant.
Douglas B. Cines focuses on Immunology, Platelet, Molecular biology, Plasminogen activator and Antibody. His Immunology research focuses on Pharmacology and how it relates to In vivo. His work in Platelet covers topics such as Heparin which are related to areas like Anticoagulant.
His studies in Molecular biology integrate themes in fields like Cell culture, Biochemistry, Binding site, Endothelium and Thrombin. Douglas B. Cines has researched Plasminogen activator in several fields, including Fibrinolysis, Plasmin and Urokinase. The study of Antibody is intertwined with the study of Antigen in a number of ways.
His primary areas of study are Platelet, Immunology, Platelet factor 4, Heparin-induced thrombocytopenia and Internal medicine. His study in Platelet is interdisciplinary in nature, drawing from both Thrombus and Fibrin. Many of his studies on Immunology apply to Tissue factor as well.
His biological study spans a wide range of topics, including Molecular biology, Antibody, Monoclonal antibody and Antigen. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Endocrinology. His research investigates the connection between Heparin and topics such as Endothelium that intersect with problems in Glycocalyx and Endothelial stem cell.
Platelet, Immunology, Platelet factor 4, Molecular biology and Heparin are his primary areas of study. His Platelet study combines topics from a wide range of disciplines, such as Fibrinolysis, Cancer research and Fibrin. His research combines Antithrombotic and Immunology.
His research on Platelet factor 4 often connects related areas such as Heparin-induced thrombocytopenia. His research in Molecular biology intersects with topics in Immune system, Urokinase receptor, Signal transduction, Cell surface receptor and Monoclonal antibody. His study looks at the relationship between Heparin and topics such as Antigen, which overlap with Complement system and Antibody.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Endothelial Cells in Physiology and in the Pathophysiology of Vascular Disorders
Douglas B. Cines;Eleanor S. Pollak;Clayton A. Buck;Joseph Loscalzo.
Blood (1998)
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
Francesco Rodeghiero;Roberto Stasi;Terry Gernsheimer;Marc Michel.
Blood (2009)
International consensus report on the investigation and management of primary immune thrombocytopenia.
Drew Provan;Roberto Stasi;Adrian C. Newland;Victor S. Blanchette.
Blood (2010)
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
JN George;SH Woolf;GE Raskob;JS Wasser.
Blood (1996)
Immune thrombocytopenic purpura.
Douglas B Cines;Victor S Blanchette.
The New England Journal of Medicine (2002)
The ITP syndrome: pathogenic and clinical diversity
Douglas B. Cines;James B. Bussel;Howard A. Liebman;Eline T. Luning Prak.
Blood (2009)
Immune endothelial-cell injury in heparin-associated thrombocytopenia
Douglas B. Cines;Ann Tomaski;Susan Tannenbaum.
The New England Journal of Medicine (1987)
American Society of Hematology 2019 guidelines for immune thrombocytopenia
Cindy Neunert;Deirdra R. Terrell;Donald M. Arnold;George Buchanan.
Blood Advances (2019)
How I treat idiopathic thrombocytopenic purpura (ITP)
Douglas B. Cines;James B. Bussel.
Blood (2005)
American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia.
Adam Cuker;Gowthami M. Arepally;Beng H. Chong;Douglas B. Cines.
Blood Advances (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Children's Hospital of Philadelphia
University of Pennsylvania
University of Pennsylvania
Cornell University
Northwestern University
University of Pennsylvania
University Hospitals of Cleveland
University of Pennsylvania
Northwestern University
Scripps Research Institute
University of Tokyo
University of West Bohemia
Western Digital (United States)
California Institute of Technology
The University of Texas at Austin
University of Patras
University of Strathclyde
Sao Paulo State University
Qatar University
University of Tsukuba
University of Oxford
University of Rhode Island
University of Göttingen
University of KwaZulu-Natal
City University of New York
University of Chicago